ENDOSCOPY WILL BECOME ONE OF THE FASTEST GROWING SECTORS IN
ENDOSCOPY WILL BECOME ONE OF THE FASTEST GROWING SECTORS IN THE MEDICAL DEVICE INDUSTRY Cheers! A new report by visiongain, a London-based business information provider, predicts that the global market for endoscopy devices will be worth $75.8bn by 2022. The market generated sales of 23.3 billion dollars in 2010. The medical device industry has experienced substantial growth in the past decade owing primarily to changes in patient demographics. A key factor in the growth of this market is endoscopy, which has progressed rapidly in recent years owing primarily to an increased patient demand for minimally invasive procedures for treatment and diagnosis purposes. Historically, endoscopy was regarded as a diagnostic procedure usually scheduled after the patient has undergone imaging scans, such as X-ray or MRI to determine the cause of their medical complaint. However, technological advancements in the field and broader applications of use in recent years has propelled the field of endoscopy, with new and innovative devices offering enhanced image quality and access to regions of the body previously thought as “difficult”. Physicians now regard endoscopy as the primary method of diagnoses and treatment, and will usually schedule this procedure ahead of an imaging scan. Hemant Mistry, healthcare industry analyst, says: “A worldwide aging population is triggering a rise in the incidence of age related disorders such as arthritis and cancer. In response there has been a surge in patient demand for minimally invasive procedures such as laparoscopic surgery. Also, the aging population is causing an increase in reported cases of colorectal cancer. Early screening procedures, such as a colonoscopy or a capsule endoscopy, can reduce the mortality rate by up to 90%. An increased patient awareness of this preventative screening method will drive the demand for gastrointestinal endoscopic procedures.” Visiongain’s research also suggests that the world endoscopy devices market may benefit from globalisation. Rapidly growing economies in countries such as Brazil, Russia, India and China (BRIC nations) is fuelling a rise in the middle class population with increased wealth. This will lead to an increased adoption of westernised lifestyles, most notably with regards to diet, prompting a rise in the incidence of conditions such as obesity and cardiovascular disease. Consequently, the number of reported laparoscopic weight-loss procedures will also increase. Furthermore, the rapid growth of these countries’ economies is also prompting a rise in healthcare spending and medical insurance cover. Visiongain predicts that the endoscopy devices market will grow rapidly to 2022. The future of the endoscopy devices market appears promising and has significant potential for growth and investment with the increasing demand for safer, less invasive therapies. This new report adds to visiongain’s wide range of analytical reports in healthcare and other industry areas.
For sample pages and further information concerning the Visiongain report Endoscopy devices: world market outlook 2012-2022 please visit http://www.visiongain.com/Report/744/Endoscop...-2012-2022 For an executive summary of this report please email: Sara Peerun at sara.peerun@visiongainglobal.com Tel: +44 (0) 20 7336 6100 Notes for Editors If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100 About visiongain Visiongain is one of the fastest growing and most innovative independent business intelligence companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters and management reports focusing on the Energy, Telecoms, Pharmaceuticals, Defence, Aviation and Materials sectors. Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.
CYduct Diagnostics Inc. (CYDX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Six solar sites and one settled insurance contract have produced a result worth studying, not celebrating with confetti. Foresight and Paratus say their completed renewable-price insurance policy generated a £14.49/MWh net uplift, after premium, against the revenue those assets would have earned under a fixed-price power purchase agreement. In a UK renewables market...
Continue Reading
A dividend notice is rarely thrilling, but it can still separate a steady utility from a story stock peddling fumes. PPL Corporation declared a quarterly common dividend of $0.2850 per share on Nov. 20, payable Jan. 4, 2027. Shareholders must be on the books by Dec. 10, 2026, to receive it. Plain vanilla stuff, yes. Still, plain vanilla is often precisely why utility...
Continue Reading
Seven years of courtroom smoke over an under-$80,000 lien is the sort of mess that makes any business owner grind his teeth. Palm Beach Polo says its president, Glenn Straub, has again prevailed against Jessica Nicodemo in Palm Beach County, following an earlier Broward County dismissal of related claims. The company also says Vice President Sal Spano received a directed...
Continue Reading
A unanimous first contract in a Milwaukee County department is not the sort of headline that rattles a trading screen, but it can tell you plenty about where the ground is moving. Public safety workers in the county Facilities Department have ratified their first agreement with Teamsters Local 344, according to the union. The vote matters less for any disclosed economic...
Continue Reading
A Crowded Singapore Room Says Something Singapore did not host a mere anniversary toast on November 18; it hosted a pretty revealing cross-section of the businesses trying to build, secure, cool, connect, finance, and digitize Asia Pacific and MEASA. Frost & Sullivan marked 65 years with its 2026 Best Practices Recognition banquet at Hilton Singapore Orchard, gathering...
Continue Reading
A $19,995 vacation is not selling a seat on a train; it is selling relief from planning, crowds and compromise. Great Rail Journeys is leaning hard into that proposition for 2027 with two additions to its premium Landmark Collection: a Europe-heavy Orient Express and Rhône cruise pairing, plus a South Africa itinerary built around safari, Victoria Falls and rail-flavored...
Continue Reading
Data centers rarely arrive bearing a gift for ordinary power customers. Yet Alabama Power says its coming load growth will help cut customer rates by $160 million in 2027, beginning with January bills. In a utility world stuffed with requests for more money, that is a sharp change of pace. The company filed the reduction with the Alabama Public Service Commission on Nov....
Continue Reading
A paint pigment, a discarded object, and a serious climate question have landed in the same room. BE OPEN Art’s 2026 Art Limitless competition is aimed at SDG 12, the United Nations goal centered on responsible production and consumption. That may sound like institutional language built for conference folders, but the underlying issue is plain enough: society cannot...
Continue Reading
A Very Large Financing Cart Rolled Out Boston Scientific just put an enormous stack of paper into the market, and nobody should mistake this for routine housekeeping. The company priced $3.0 billion of U.S. dollar senior notes and €4.25 billion of euro notes, with proceeds earmarked chiefly for the cash portion of its proposed Penumbra acquisition, alongside cash on...
Continue Reading
A 35-minute fireside chat can be a whole lot of nothing, or it can leave a useful breadcrumb trail for shareholders willing to listen closely. S&P Global has put December 8, 2026 on the calendar, when Chief Executive Officer Martina Cheung is scheduled to appear at Goldman Sachs' 2026 Financial Services Conference in New York. Her slot runs from 5:00 p.m. to 5:35 p.m....
Continue Reading
Top 5 Most Recently Viewed Articles
Bearish Sentiments in Goldman Sachs Group Options Recent activity in the financial market has brought to light the bearish stance among significant investors regarding Goldman Sachs Group (NYSE: GS). While it’s important for retail traders to stay informed, this trend signifies that something noteworthy may be unfolding within the company. Insights from Options...
Continue Reading
Calamos Investments Introduces Unique Bitcoin ETFs Offering Significant Protection Calamos Investments has recently made headlines with the launch of two groundbreaking exchange-traded funds (ETFs), designed to provide investors with innovative exposure to Bitcoin while maintaining notable downside protection. These new ETFs, namely the CBXJ and CBTJ, offer 90% and 80%...
Continue Reading
Mawson Infrastructure Group's Notable Q3 Performance Mawson Infrastructure Group Inc. (NASDAQ: MIGI) is a technology company focused on establishing and managing advanced digital infrastructure platforms. The company recently revealed its financial and operational results, marking the conclusion of the third quarter and the year-to-date for 2025. Financial Highlights from...
Continue Reading
Nékter Juice Bar Launches Exciting Smoothie Collaboration The Krista Kolada Combines Clean Ingredients with Social Power Nékter Juice Bar, a leading name in providing fresh and healthy juice options, has recently rolled out a delightful new offering for its fans. The introduction of the Krista Kolada smoothie marks an exciting collaboration with lifestyle and parenting...
Continue Reading
Kintara Therapeutics Announces Record Date for CVR Issuance Kintara Therapeutics, Inc. (NASDAQ: KTRA), a biopharmaceutical company dedicated to developing innovative therapies for solid tumors, recently revealed a record date for the issuance of Contingent Value Rights (CVRs). These rights will be granted to stockholders of Kintara as part of its forthcoming merger with...
Continue Reading